Blog
Guías prácticas para protocolos de péptidos.
Contenido educativo sobre seguimiento, cálculos de dosis, conservación, analíticas y diseño de protocolos. Cada artículo lo revisa una persona y no contiene consejo médico.
Las guías están escritas en inglés.
Las 143 guías de péptidos
Busca por nombre o toca un beneficio para encontrar el péptido adecuado para lo que quieres.
Filtrar por beneficio
Mostrando 24 de 142 guías de péptidos.
MK-677 (Ibutamoren): A Tracking Guide for an Oral GH Secretagogue
A measured, harm-reduction look at MK-677, what it actually does to GH and IGF-1, and the daily signals and bloodwork worth watching.
Bueno para
Oral Semaglutide 25 mg: A Tracking Guide for the Wegovy Pill
A neutral, harm-reduction guide to the oral semaglutide weight-management pill, its strict dosing rules, and what to monitor.
Bueno para
Ostarine (MK-2866): A Tracking Guide for the Most-Studied SARM
A neutral, harm-reduction look at ostarine, why it is the mildest of the SARMs, and what to monitor given it still suppresses natural hormones.
Bueno para
CagriSema: A Tracking Guide for a Cagrilintide and Semaglutide Combination
A harm-reduction look at CagriSema, an investigational amylin-plus-GLP-1 combination not yet approved, and what would be worth tracking.
Bueno para
Ligandrol (LGD-4033): A Tracking Guide for a Potent Mass-Building SARM
A harm-reduction look at ligandrol, why its strength comes with strong hormonal suppression, and the monitoring that actually matters.
Bueno para
Mazdutide: A Tracking Guide for a Glucagon and GLP-1 Dual Agonist
A neutral, harm-reduction guide to mazdutide, a dual glucagon/GLP-1 agonist approved in China, and what to monitor.
Bueno para
RAD-140 (Testolone): A Tracking Guide for a Strong Lean-Mass SARM
A harm-reduction look at RAD-140, its strong anabolic effect, the reported liver-injury signals, and what to monitor closely.
Bueno para
Survodutide: A Tracking Guide for a GLP-1 and Glucagon Dual Agonist
A harm-reduction look at survodutide, an investigational GLP-1/glucagon agonist with obesity and MASH data, not yet approved.
Bueno para
Cardarine (GW-501516): A Tracking Guide for a PPAR-Delta Agonist
A candid, harm-reduction look at cardarine, its endurance and fat-oxidation effects, and the rodent carcinogenicity signal that ended its development.
Bueno para
Amycretin: A Tracking Guide for a GLP-1 and Amylin Agonist
A neutral, harm-reduction guide to amycretin, an investigational GLP-1/amylin agonist in oral and injectable forms, entering Phase 3.
Bueno para
Andarine (S4): A Tracking Guide for an Older Cutting SARM
A harm-reduction look at andarine, its use in cutting phases, and the reversible vision side effect that sets it apart from other SARMs.
Bueno para
VK2735: A Tracking Guide for a GIP and GLP-1 Dual Agonist
A harm-reduction look at VK2735, an investigational GIP/GLP-1 agonist in oral and injectable Phase 3 programs, not yet approved.
Bueno para
YK-11: A Tracking Guide for a Steroidal Myostatin-Claim Compound
A harm-reduction look at YK-11, a steroidal compound sold as a SARM with myostatin-inhibition claims, and why the human evidence is essentially absent.
Bueno para
Pemvidutide: A Tracking Guide for a GLP-1 and Glucagon Agonist
A neutral, harm-reduction guide to pemvidutide, an investigational GLP-1/glucagon agonist noted for lean-mass sparing and MASH data.
Bueno para
Stenabolic (SR9009): A Tracking Guide for a REV-ERB Exercise Mimetic
A harm-reduction look at SR9009, its exercise-mimetic claims, and the poor oral bioavailability that undercuts most real-world use.
Bueno para
Bimagrumab: A Tracking Guide for an Activin Receptor Antibody
A harm-reduction look at bimagrumab, an investigational antibody that lowers fat while preserving or adding muscle, studied with semaglutide.
Bueno para
Enclomiphene: A Tracking Guide for a Fertility-Preserving SERM
A measured, harm-reduction look at enclomiphene, why it is used instead of exogenous testosterone, and the bloodwork that tells you whether it is working.
Bueno para
Superdrol (Methasterone): A Tracking Guide for a Harsh Oral Steroid
A harm-reduction look at methasterone, a potent and markedly hepatotoxic oral steroid, and the monitoring that matters most if someone has already decided to use it.
Bueno para
Cabergoline: A Tracking Guide for a Prolactin-Lowering Dopamine Agonist
A cautious, harm-reduction look at cabergoline, why it is used to manage prolactin, and the cardiac risk that has to be taken seriously.
Bueno para
Halotestin (Fluoxymesterone): A Tracking Guide for a Potent Oral Androgen
A harm-reduction look at fluoxymesterone, a strong oral steroid used pre-competition for strength and aggression, with honest framing of its liver and lipid risks.
Bueno para
Raloxifene: A Tracking Guide for a Gynecomastia-Focused SERM
A measured, harm-reduction look at raloxifene, why it is often preferred for treating gynecomastia, and the clotting risk to watch.
Bueno para
Proviron (Mesterolone): A Tracking Guide for an Oral DHT Derivative
A measured look at mesterolone, a weakly anabolic oral DHT derivative used as an adjunct to lower SHBG and support libido, and what is worth tracking.
Bueno para
Toremifene: A Tracking Guide for a Tamoxifen-Like SERM
A measured, harm-reduction look at toremifene, how it compares to tamoxifen, and what to monitor when it is used for gyno control or PCT.
Bueno para
Trestolone (MENT): A Tracking Guide for a Potent 19-Nor Injectable
A harm-reduction look at trestolone, a very potent nandrolone-like injectable that is strongly suppressive and aromatizes to a potent estrogen, and what to monitor.
Bueno para